Commercial Litigation Firms
Court-ready business valuation reports, shadow expert advisory, and forensic accounting models built to withstand rigorous cross-examination.
For Legal Professionals
Matters prepared to CPR Part 35 where applicable.
Independent valuation and forensic accounting for commercial litigation, corporate deadlocks, and cross-border shareholder conflicts.
Court-ready business valuation reports, shadow expert advisory, and forensic accounting models built to withstand rigorous cross-examination.
For Legal ProfessionalsDefinitive and independent evaluation of fair value or economic loss when facing exclusion, corporate deadlock, or minority oppression.
For Business PartnersForensic investigation into portfolio companies where asset diversion, director misfeasance, or breaches of shareholder agreements are suspected.
For Institutional FundsIndependent analysis of quantum, liability, and accounting regularities in high-value director and officer liability proceedings.
For InsurersSpecialist pathways covering unfair prejudice petitions, contentious valuations, partnership dissolutions, derivative claims, and SJE appointments.
Expert accounting evidence for petitions under Section 994 of the Companies Act 2006 - quantifying prejudice, dividend starvation, and minority discount disputes.
ViewContentious corporate valuations using DCF, capitalised earnings, and adjusted net asset methodologies - defensible under rigorous legal scrutiny.
ViewForensic accounting for partnerships, LPs, and LLPs under the Partnership Act 1890 - drawing reconciliations, goodwill apportionment, and dissolution schedules.
ViewValuation mapping for closely-held companies functioning as partnerships - undiscounted fair value under mutual trust assumptions.
ViewReconstruction of corporate cash flows, inter-company loans, and hidden asset diversions to support derivative claims and asset recovery.
ViewExpert witness support for derivative actions - quantifying director misfeasance, asset siphoning, and commercial waste under Companies Act 2006.
ViewNeutral Single Joint Expert appointments on company valuation and forensic accounting - balanced fact-finding with duty to the court.
View
Shareholder Dispute Expert is a corporate finance advisory and forensic accounting expert witness practice specializing in independent business valuations and loss quantification for shareholder disputes, unfair prejudice petitions, partnership dissolutions, and contentious private equity actions. Reports are prepared to Civil Procedure Rules (CPR) Part 35 standards where applicable.
Contentious business valuation and forensic accounting for shareholder and corporate conflicts.
Maintainable earnings are isolated through forensic normalization, then capitalised or discounted using defensible growth and risk assumptions tied to market evidence.
Comparable company and transaction multiples are applied only where the subject entity and dispute context support reliable benchmarking.
Adjusted net asset values are used where earnings are unreliable, in asset-heavy businesses, or where liquidation or break-up scenarios are in issue.
Articles, shareholders' agreements, and quasi-partnership assumptions determine whether a pro-rata or discounted minority stake is the correct economic outcome.
In shareholder conflicts, breach of agreement or unfair prejudice is frequently conceded or close to determination. The core conflict centers on valuation: the date of valuation, minority discounts, and normalization of earnings. Rigorous, independent financial evidence dictates the exit terms.
Majority shareholders masking distributions as management charges, hiding assets in subsidiary webs, or suppressing margins to freeze out minority interests require advanced forensic tracking. General accounting audits do not catch deliberate value extraction.
Shareholder disputes in UK courts involve high-caliber commercial counsel. Valuation methodologies (DCF, EBITDA multiples, Net Asset adjustments) must be perfectly defensible, logically bulletproof, and fully compliant with CPR Part 35 requirements.
Eight forensic valuation sub-sectors mapped to the core financial battlegrounds in shareholder and corporate disputes.
01
Context: Unfair prejudice claims under the Companies Act 2006
Focus: Normalized earnings tracking, dividend starvation analysis, management extraction auditing
02
Context: Disputes over fair value vs discounted minority stake valuations
Focus: Articles of Association evaluation, shareholder agreement analysis, fair value multi-track mapping
03
Context: Director misfeasance and shadow director conduct
Focus: Director misfeasance tracking, shadow director tracing, hidden commissions extraction auditing
04
Context: Distorted profitability masking true maintainable earnings
Focus: Striking personal expenses, reversing uncommercial transactions, adjusting sibling company pricing
05
Context: Conflicting valuation dates fundamentally altering quantum
Focus: Petition-date counterfactuals, hearing-date models, exclusion point liquidity matrices
06
Context: Suspected diversion through corporate structures
Focus: Multi-layered corporate veil audits, shell tracking, bank ledger reconstruction
07
Context: Partnership, LP, and LLP breakups and winding-up
Focus: Partnership Act 1890 accounting, drawing account reconciliations, market goodwill splits
08
Context: JV revenue splits and capital contribution disputes
Focus: Capital contribution tracking, operational revenue splits auditing, asset allocation metrics

Immediate, strict conflict clearance followed by baseline onboarding of case parameters and timeline constraints.
Secure acquisition of statutory books, management accounts, general ledgers, banking lines, and transaction trails.
Reconstructing financial realities to model corporate value but for the alleged prejudicial actions or breaches.
Provision of a clean, comprehensive CPR Part 35 compliant report, Joint Statement text, or oral cross-examination support.
Fair value in private company shareholder disputes is generally determined by establishing the pro-rata enterprise value of the corporate entity as a whole, typically utilizing earnings multiples (EV/EBITDA) or discounted cash flow (DCF) models, and adjusting for normalization vectors. In cases of unfair prejudice under Section 994, the High Court frequently directs that the valuation should exclude any minority discount, treating the enterprise as a quasi-partnership to achieve an equitable exit.
A minority discount reflects the reduced commercial control and lack of marketability inherent in a minority shareholding block. In standard corporate transactions, this discount can range from 10% to over 50%. However, in Section 994 unfair prejudice petitions, if the corporate entity is classified as a 'quasi-partnership' founded on mutual trust and an assumption of active participation, the court typically rules that the petitioner's shares must be purchased at full pro-rata value without any minority discount application.
The High Court retains absolute overriding discretion to determine the valuation date that achieves fairness. The default baseline is typically the date of the judicial determination (the trial date) or the date the petition was formally issued. If the majority has deliberately suppressed or siphoned company value post-exclusion, the court will backdate the valuation to the date of exclusion, or reconstruct the company's financial model to neutralize the prejudicial actions.
Normalizing EBITDA involves adjusting a private company's historical profit-and-loss statements to reveal its true underlying maintainable earnings on an arm's-length commercial basis. A forensic accountant strips out excessive above-market director salaries, non-commercial intercompany transfer pricing, personal expenses run through the business, non-recurring transaction legal fees, and arbitrary management adjustments, aligning the financial baseline with real market conditions.
To satisfy Civil Procedure Rules Part 35 and Practice Direction 35, a business valuation report must: be addressed explicitly to the court rather than the instructing client; document the expert's professional credentials; outline the explicit and implied instructions received; delineate the core facts, source accounts, and baseline assumptions applied; present clear technical reasoning for the chosen valuation metrics; define any applicable ranges of valuation opinions; provide a structured summary of financial conclusions; contain a formal statement confirming compliance with expert duties; and be signed under a strict regulatory statement of truth.
We run conflict checks before confirming any engagement.
Instruct an expert